Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 20 entries
Sorted by: Best Match Show Resources per page
Synthesis and characterization of facial and meridional tris-cyclometalated iridium(III) complexes.

Journal of the American Chemical Society

Tamayo AB, Alleyne BD, Djurovich PI, Lamansky S, Tsyba I, Ho NN, Bau R, Thompson ME.
PMID: 12797812
J Am Chem Soc. 2003 Jun 18;125(24):7377-87. doi: 10.1021/ja034537z.

The synthesis, structures, electrochemistry, and photophysics of a series of facial (fac) and meridional (mer) tris-cyclometalated Ir(III) complexes are reported. The complexes have the general formula Ir(C'N)(3) [where C'N is a monoanionic cyclometalating ligand; 2-phenylpyridyl (ppy), 2-(p-tolyl)pyridyl (tpy), 2-(4,6-difluorophenyl)pyridyl...

Cite
Tamayo AB, Alleyne BD, Djurovich PI, et al. Synthesis and characterization of facial and meridional tris-cyclometalated iridium(III) complexes. J Am Chem Soc. 2003;125(24):7377-87doi: 10.1021/ja034537z.
Tamayo, A. B., Alleyne, B. D., Djurovich, P. I., Lamansky, S., Tsyba, I., Ho, N. N., Bau, R., & Thompson, M. E. (2003). Synthesis and characterization of facial and meridional tris-cyclometalated iridium(III) complexes. Journal of the American Chemical Society, 125(24), 7377-87. https://doi.org/10.1021/ja034537z
Tamayo, Arnold B, et al. "Synthesis and characterization of facial and meridional tris-cyclometalated iridium(III) complexes." Journal of the American Chemical Society vol. 125,24 (2003): 7377-87. doi: https://doi.org/10.1021/ja034537z
Tamayo AB, Alleyne BD, Djurovich PI, Lamansky S, Tsyba I, Ho NN, Bau R, Thompson ME. Synthesis and characterization of facial and meridional tris-cyclometalated iridium(III) complexes. J Am Chem Soc. 2003 Jun 18;125(24):7377-87. doi: 10.1021/ja034537z. PMID: 12797812.
Copy Download .nbib Format: NLM
Intermolecular activation of hydrocarbon C-H bonds under ambient conditions by 16-electron neopentylidene and benzyne complexes of molybdenum.

Journal of the American Chemical Society

Wada K, Pamplin CB, Legzdins P, Patrick BO, Tsyba I, Bau R.
PMID: 12783558
J Am Chem Soc. 2003 Jun 11;125(23):7035-48. doi: 10.1021/ja0349094.

CpMo(NO)(CH(2)CMe(3))(2) (1), a complex with alpha-agostic C-H.Mo interactions, evolves neopentane in neat hydrocarbon solutions at room temperature and forms the transient 16-electron alkylidene complex, CpMo(NO)(=CHCMe(3)), which subsequently activates solvent C-H bonds. Thus, it reacts with tetramethylsilane or mesitylene to...

Cite
Wada K, Pamplin CB, Legzdins P, et al. Intermolecular activation of hydrocarbon C-H bonds under ambient conditions by 16-electron neopentylidene and benzyne complexes of molybdenum. J Am Chem Soc. 2003;125(23):7035-48doi: 10.1021/ja0349094.
Wada, K., Pamplin, C. B., Legzdins, P., Patrick, B. O., Tsyba, I., & Bau, R. (2003). Intermolecular activation of hydrocarbon C-H bonds under ambient conditions by 16-electron neopentylidene and benzyne complexes of molybdenum. Journal of the American Chemical Society, 125(23), 7035-48. https://doi.org/10.1021/ja0349094
Wada, Kenji, et al. "Intermolecular activation of hydrocarbon C-H bonds under ambient conditions by 16-electron neopentylidene and benzyne complexes of molybdenum." Journal of the American Chemical Society vol. 125,23 (2003): 7035-48. doi: https://doi.org/10.1021/ja0349094
Wada K, Pamplin CB, Legzdins P, Patrick BO, Tsyba I, Bau R. Intermolecular activation of hydrocarbon C-H bonds under ambient conditions by 16-electron neopentylidene and benzyne complexes of molybdenum. J Am Chem Soc. 2003 Jun 11;125(23):7035-48. doi: 10.1021/ja0349094. PMID: 12783558.
Copy Download .nbib Format: NLM
Successful treatment of erythematotelangiectatic rosacea with pulsed light and radiofrequency.

The Journal of clinical and aesthetic dermatology

Taub AF, Devita EC.
PMID: 21103309
J Clin Aesthet Dermatol. 2008 May;1(1):37-40.

INTRODUCTION: Many laser and light devices have reported to be successful in the treatment of the flushing, background erythema, and telangiectasias that characterize erythematotelangiectatic rosacea including pulsed dye laser, potassium titanyl phosphate, intense pulsed light, and dual-wavelength lasers. A...

Cite
Taub AF, Devita EC. Successful treatment of erythematotelangiectatic rosacea with pulsed light and radiofrequency. J Clin Aesthet Dermatol. 2008;1(1):37-40
Taub, A. F., & Devita, E. C. (2008). Successful treatment of erythematotelangiectatic rosacea with pulsed light and radiofrequency. The Journal of clinical and aesthetic dermatology, 1(1), 37-40.
Taub, Amy Forman, and Devita, Erin C. "Successful treatment of erythematotelangiectatic rosacea with pulsed light and radiofrequency." The Journal of clinical and aesthetic dermatology vol. 1,1 (2008): 37-40.
Taub AF, Devita EC. Successful treatment of erythematotelangiectatic rosacea with pulsed light and radiofrequency. J Clin Aesthet Dermatol. 2008 May;1(1):37-40. PMID: 21103309; PMCID: PMC2989806.
Copy Download .nbib Format: NLM
Monoc programme: Scientific substantiation of the integrated global ocean ecological monitoring system.

Environmental monitoring and assessment

Tsyban AV, Izrael YA.
PMID: 24248969
Environ Monit Assess. 1988 Jan;11(3):279-92. doi: 10.1007/BF00394677.

Man's exploitation of the World Ocean continues to increase both productively, i.e., utilization of fisheries and natural resources, and counterproductively, i.e., increased pollutant loading. This paper presents a scientific rationale for a global ecological monitoring programme which will address...

Cite
Tsyban AV, Izrael YA. Monoc programme: Scientific substantiation of the integrated global ocean ecological monitoring system. Environ Monit Assess. 1988;11(3):279-92doi: 10.1007/BF00394677.
Tsyban, A. V., & Izrael, Y. A. (1988). Monoc programme: Scientific substantiation of the integrated global ocean ecological monitoring system. Environmental monitoring and assessment, 11(3), 279-92. https://doi.org/10.1007/BF00394677
Tsyban, A V, and Izrael, Y A. "Monoc programme: Scientific substantiation of the integrated global ocean ecological monitoring system." Environmental monitoring and assessment vol. 11,3 (1988): 279-92. doi: https://doi.org/10.1007/BF00394677
Tsyban AV, Izrael YA. Monoc programme: Scientific substantiation of the integrated global ocean ecological monitoring system. Environ Monit Assess. 1988 Jan;11(3):279-92. doi: 10.1007/BF00394677. PMID: 24248969.
Copy Download .nbib Format: NLM
Synthesis and characterization of phosphorescent cyclometalated iridium complexes.

Inorganic chemistry

Lamansky S, Djurovich P, Murphy D, Abdel-Razzaq F, Kwong R, Tsyba I, Bortz M, Mui B, Bau R, Thompson ME.
PMID: 11261983
Inorg Chem. 2001 Mar 26;40(7):1704-11. doi: 10.1021/ic0008969.

The preparation, photophysics, and solid state structures of octahedral organometallic Ir complexes with several different cyclometalated ligands are reported. IrCl3.nH2O cleanly cyclometalates a number of different compounds (i.e., 2-phenylpyridine, 2-(p-tolyl)pyridine, benzoquinoline, 2-phenylbenzothiazole, 2-(1-naphthyl)benzothiazole, and 2-phenylquinoline), forming the corresponding chloride-bridged...

Cite
Lamansky S, Djurovich P, Murphy D, et al. Synthesis and characterization of phosphorescent cyclometalated iridium complexes. Inorg Chem. 2001;40(7):1704-11doi: 10.1021/ic0008969.
Lamansky, S., Djurovich, P., Murphy, D., Abdel-Razzaq, F., Kwong, R., Tsyba, I., Bortz, M., Mui, B., Bau, R., & Thompson, M. E. (2001). Synthesis and characterization of phosphorescent cyclometalated iridium complexes. Inorganic chemistry, 40(7), 1704-11. https://doi.org/10.1021/ic0008969
Lamansky, S, et al. "Synthesis and characterization of phosphorescent cyclometalated iridium complexes." Inorganic chemistry vol. 40,7 (2001): 1704-11. doi: https://doi.org/10.1021/ic0008969
Lamansky S, Djurovich P, Murphy D, Abdel-Razzaq F, Kwong R, Tsyba I, Bortz M, Mui B, Bau R, Thompson ME. Synthesis and characterization of phosphorescent cyclometalated iridium complexes. Inorg Chem. 2001 Mar 26;40(7):1704-11. doi: 10.1021/ic0008969. PMID: 11261983.
Copy Download .nbib Format: NLM
[Death of prof. Dr. Frantisek Hora].

Casopis lekaru ceskych

TRYB A.
PMID: 13250554
Cas Lek Cesk. 1955 Jul 15;94(29):781-2.

No abstract available.

Cite
TRYB A. Profesor Mudr Frantisek Hora zemrel. [Death of prof. Dr. Frantisek Hora]. Cas Lek Cesk. 1955;94(29):781-2
TRYB, A. (1955). Profesor Mudr Frantisek Hora zemrel. [Death of prof. Dr. Frantisek Hora]. Casopis lekaru ceskych, 94(29), 781-2.
TRYB, A. "Profesor Mudr Frantisek Hora zemrel." [Death of prof. Dr. Frantisek Hora]. Casopis lekaru ceskych vol. 94,29 (1955): 781-2.
TRYB A. Profesor Mudr Frantisek Hora zemrel. [Death of prof. Dr. Frantisek Hora]. Cas Lek Cesk. 1955 Jul 15;94(29):781-2. Czech. PMID: 13250554.
Copy Download .nbib Format: NLM
Treatment of Acne Scars of Skin Types II to V by Sublative Fractional Bipolar Radiofrequency and Bipolar Radiofrequency Combined with Diode Laser.

The Journal of clinical and aesthetic dermatology

Taub AF, Garretson CB.
PMID: 22010052
J Clin Aesthet Dermatol. 2011 Oct;4(10):18-27.

OBJECTIVE: This study evaluated the safety and efficacy of sublative fractional bipolar radiofrequency and bipolar radio frequency combined with diode laser for the treatment of both superficial and deep acne scars in patients with skin types II to V.DESIGN:...

Cite
Taub AF, Garretson CB. Treatment of Acne Scars of Skin Types II to V by Sublative Fractional Bipolar Radiofrequency and Bipolar Radiofrequency Combined with Diode Laser. J Clin Aesthet Dermatol. 2011;4(10):18-27
Taub, A. F., & Garretson, C. B. (2011). Treatment of Acne Scars of Skin Types II to V by Sublative Fractional Bipolar Radiofrequency and Bipolar Radiofrequency Combined with Diode Laser. The Journal of clinical and aesthetic dermatology, 4(10), 18-27.
Taub, Amy Forman, and Garretson, Cara Beth. "Treatment of Acne Scars of Skin Types II to V by Sublative Fractional Bipolar Radiofrequency and Bipolar Radiofrequency Combined with Diode Laser." The Journal of clinical and aesthetic dermatology vol. 4,10 (2011): 18-27.
Taub AF, Garretson CB. Treatment of Acne Scars of Skin Types II to V by Sublative Fractional Bipolar Radiofrequency and Bipolar Radiofrequency Combined with Diode Laser. J Clin Aesthet Dermatol. 2011 Oct;4(10):18-27. PMID: 22010052; PMCID: PMC3196304.
Copy Download .nbib Format: NLM
Cationic bis-cyclometalated iridium(III) diimine complexes and their use in efficient blue, green, and red electroluminescent devices.

Inorganic chemistry

Tamayo AB, Garon S, Sajoto T, Djurovich PI, Tsyba IM, Bau R, Thompson ME.
PMID: 16296826
Inorg Chem. 2005 Nov 28;44(24):8723-32. doi: 10.1021/ic050970t.

A series of cationic Ir(III) complexes with the general formula (C/N)2Ir(N/N)(+)PF6- featuring bis-cyclometalated 1-phenylpyrazolyl-N,C2' (C/N) and neutral diimine (N/N, e.g., 2,2'-bipyridyl) ligands were synthesized and their electrochemical, photophysical, and electroluminescent properties studied. Density functional theory calculations indicate that the...

Cite
Tamayo AB, Garon S, Sajoto T, et al. Cationic bis-cyclometalated iridium(III) diimine complexes and their use in efficient blue, green, and red electroluminescent devices. Inorg Chem. 2005;44(24):8723-32doi: 10.1021/ic050970t.
Tamayo, A. B., Garon, S., Sajoto, T., Djurovich, P. I., Tsyba, I. M., Bau, R., & Thompson, M. E. (2005). Cationic bis-cyclometalated iridium(III) diimine complexes and their use in efficient blue, green, and red electroluminescent devices. Inorganic chemistry, 44(24), 8723-32. https://doi.org/10.1021/ic050970t
Tamayo, Arnold B, et al. "Cationic bis-cyclometalated iridium(III) diimine complexes and their use in efficient blue, green, and red electroluminescent devices." Inorganic chemistry vol. 44,24 (2005): 8723-32. doi: https://doi.org/10.1021/ic050970t
Tamayo AB, Garon S, Sajoto T, Djurovich PI, Tsyba IM, Bau R, Thompson ME. Cationic bis-cyclometalated iridium(III) diimine complexes and their use in efficient blue, green, and red electroluminescent devices. Inorg Chem. 2005 Nov 28;44(24):8723-32. doi: 10.1021/ic050970t. PMID: 16296826.
Copy Download .nbib Format: NLM
Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors.

Oncotarget

Ponomarenko DM, Klimova ID, Chapygina YA, Dvornichenko VV, Zhukova NV, Orlova RV, Manikhas GM, Zyryanov AV, Burkhanova LA, Badrtdinova II, Oshchepkov BN, Filippova EV, Orlov SV, Kolesnikov SI, Sufianov AA, Baum SR, Zaitzeva OY, Komissarov AB, Grudinin MP, Kiselev OI, Tsyb AF, Venanzi F, Shcherbinina V, Chursov A, Gabai VL, Shneider AM.
PMID: 28881846
Oncotarget. 2017 Mar 25;8(32):53730-53739. doi: 10.18632/oncotarget.16574. eCollection 2017 Aug 08.

Elenagen is a plasmid encoding p62/SQSTM1, the first DNA vaccine possessing two mutually complementing mechanisms of action: it elicits immune response against p62 and mitigates systemic chronic inflammation. Previously, Elenagen demonstrated anti-tumor efficacy and safety in rodent tumor models...

Cite
Ponomarenko DM, Klimova ID, Chapygina YA, et al. Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors. Oncotarget. 2017;8(32):53730-53739doi: 10.18632/oncotarget.16574.
Ponomarenko, D. M., Klimova, I. D., Chapygina, Y. A., Dvornichenko, V. V., Zhukova, N. V., Orlova, R. V., Manikhas, G. M., Zyryanov, A. V., Burkhanova, L. A., Badrtdinova, I. I., Oshchepkov, B. N., Filippova, E. V., Orlov, S. V., Kolesnikov, S. I., Sufianov, A. A., Baum, S. R., Zaitzeva, O. Y., Komissarov, A. B., Grudinin, M. P., Kiselev, O. I., Tsyb, A. F., Venanzi, F., Shcherbinina, V., Chursov, A., Gabai, V. L., & Shneider, A. M. (2017). Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors. Oncotarget, 8(32), 53730-53739. https://doi.org/10.18632/oncotarget.16574
Ponomarenko, Dmitry M, et al. "Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors." Oncotarget vol. 8,32 (2017): 53730-53739. doi: https://doi.org/10.18632/oncotarget.16574
Ponomarenko DM, Klimova ID, Chapygina YA, Dvornichenko VV, Zhukova NV, Orlova RV, Manikhas GM, Zyryanov AV, Burkhanova LA, Badrtdinova II, Oshchepkov BN, Filippova EV, Orlov SV, Kolesnikov SI, Sufianov AA, Baum SR, Zaitzeva OY, Komissarov AB, Grudinin MP, Kiselev OI, Tsyb AF, Venanzi F, Shcherbinina V, Chursov A, Gabai VL, Shneider AM. Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors. Oncotarget. 2017 Mar 25;8(32):53730-53739. doi: 10.18632/oncotarget.16574. eCollection 2017 Aug 08. PMID: 28881846; PMCID: PMC5581145.
Copy Download .nbib Format: NLM
Synthesis and characterization of phosphorescent cyclometalated platinum complexes.

Inorganic chemistry

Brooks J, Babayan Y, Lamansky S, Djurovich PI, Tsyba I, Bau R, Thompson ME.
PMID: 12054983
Inorg Chem. 2002 Jun 17;41(12):3055-66. doi: 10.1021/ic0255508.

The synthesis, electrochemistry, and photophysics of a series of square planar Pt(II) complexes are reported. The complexes have the general structure C(wedge)NPt(O(wedge)O),where C(wedge)N is a monoanionic cyclometalating ligand (e.g., 2-phenylpyridyl, 2-(2'-thienyl)pyridyl, 2-(4,6-difluorophenyl)pyridyl, etc.) and O(wedge)O is a beta-diketonato ligand....

Cite
Brooks J, Babayan Y, Lamansky S, et al. Synthesis and characterization of phosphorescent cyclometalated platinum complexes. Inorg Chem. 2002;41(12):3055-66doi: 10.1021/ic0255508.
Brooks, J., Babayan, Y., Lamansky, S., Djurovich, P. I., Tsyba, I., Bau, R., & Thompson, M. E. (2002). Synthesis and characterization of phosphorescent cyclometalated platinum complexes. Inorganic chemistry, 41(12), 3055-66. https://doi.org/10.1021/ic0255508
Brooks, Jason, et al. "Synthesis and characterization of phosphorescent cyclometalated platinum complexes." Inorganic chemistry vol. 41,12 (2002): 3055-66. doi: https://doi.org/10.1021/ic0255508
Brooks J, Babayan Y, Lamansky S, Djurovich PI, Tsyba I, Bau R, Thompson ME. Synthesis and characterization of phosphorescent cyclometalated platinum complexes. Inorg Chem. 2002 Jun 17;41(12):3055-66. doi: 10.1021/ic0255508. PMID: 12054983.
Copy Download .nbib Format: NLM
Organometallic complexes as hole-transporting materials in organic light-emitting diodes.

Inorganic chemistry

Ren X, Alleyne BD, Djurovich PI, Adachi C, Tsyba I, Bau R, Thompson ME.
PMID: 14989662
Inorg Chem. 2004 Mar 08;43(5):1697-707. doi: 10.1021/ic035183f.

The use of metal complexes fac-tris(1-phenylpyrazolato-N,C(2)('))cobalt(III) [fac-Co(ppz)(3)], fac-tris(2-phenylpyridinato-N,C(2)(') cobalt(III) [fac-Co(ppy)(3)], and [tris[2-((pyrrole-2-ylmethylidene)amino)ethyl]amine]gallium(III) [Ga(pma)] as materials for hole-transporting layers (HTL) in organic light-emitting diodes (OLEDs) is reported. Co(ppz)(3) and Co(ppy)(3) were prepared by following literature procedures and isolated as mixtures...

Cite
Ren X, Alleyne BD, Djurovich PI, et al. Organometallic complexes as hole-transporting materials in organic light-emitting diodes. Inorg Chem. 2004;43(5):1697-707doi: 10.1021/ic035183f.
Ren, X., Alleyne, B. D., Djurovich, P. I., Adachi, C., Tsyba, I., Bau, R., & Thompson, M. E. (2004). Organometallic complexes as hole-transporting materials in organic light-emitting diodes. Inorganic chemistry, 43(5), 1697-707. https://doi.org/10.1021/ic035183f
Ren, Xiaofan, et al. "Organometallic complexes as hole-transporting materials in organic light-emitting diodes." Inorganic chemistry vol. 43,5 (2004): 1697-707. doi: https://doi.org/10.1021/ic035183f
Ren X, Alleyne BD, Djurovich PI, Adachi C, Tsyba I, Bau R, Thompson ME. Organometallic complexes as hole-transporting materials in organic light-emitting diodes. Inorg Chem. 2004 Mar 08;43(5):1697-707. doi: 10.1021/ic035183f. PMID: 14989662.
Copy Download .nbib Format: NLM
[Impact of adjuvant therapy with lithium carbonate on the results of radioiodine treatment in patients with diffuse toxic goiter].

Problemy endokrinologii

Dreval AV, Tsyb AF, Nechayeva OA, Komerdus IV, Drozdovsky BY, Carbuzov PI, Guseva TN.
PMID: 31627560
Probl Endokrinol (Mosk). 2007 Dec 15;53(6):15-19. doi: 10.14341/probl200753615-19.

Thirty-eight patients with diffuse toxic goiter (Graves' disease) were treated with radioiodine. Before 131I therapy thyrotoxicosis compensation was achieved by antithyroid medication in all the patients. Antithyroid medication was discontinued 10 days before radioiodine treatment. After its withdrawal, the...

Cite
Dreval AV, Tsyb AF, Nechayeva OA, et al. [Impact of adjuvant therapy with lithium carbonate on the results of radioiodine treatment in patients with diffuse toxic goiter]. Probl Endokrinol (Mosk). 2007;53(6):15-19doi: 10.14341/probl200753615-19.
Dreval, A. V., Tsyb, A. F., Nechayeva, O. A., Komerdus, I. V., Drozdovsky, B. Y., Carbuzov, P. I., & Guseva, T. N. (2007). [Impact of adjuvant therapy with lithium carbonate on the results of radioiodine treatment in patients with diffuse toxic goiter]. Problemy endokrinologii, 53(6), 15-19. https://doi.org/10.14341/probl200753615-19
Dreval, A V, et al. "[Impact of adjuvant therapy with lithium carbonate on the results of radioiodine treatment in patients with diffuse toxic goiter]." Problemy endokrinologii vol. 53,6 (2007): 15-19. doi: https://doi.org/10.14341/probl200753615-19
Dreval AV, Tsyb AF, Nechayeva OA, Komerdus IV, Drozdovsky BY, Carbuzov PI, Guseva TN. [Impact of adjuvant therapy with lithium carbonate on the results of radioiodine treatment in patients with diffuse toxic goiter]. Probl Endokrinol (Mosk). 2007 Dec 15;53(6):15-19. doi: 10.14341/probl200753615-19. Russian. PMID: 31627560.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 20 entries